価格表
在庫・価格 : 2024年06月13日 11時53分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-SARS-CoV-2 (COVID-19) Nucleocapsid, Rabbit-Poly データシート |
GTX135357 |
GNTジーンテックス GeneTex International Corporation |
25 μl | ¥24,000 |
無 (未発注) |
追加 |
在庫・価格 : 2024年06月13日 11時53分 現在
使用文献
- No.: 1
-
文献情報:
Corbett KS et al. Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. N. Engl. J. Med. 2020 07;
Corbett KS et al
2020/01/01
-
備考:
Application: IHC-P -
参照:
- No.: 2
-
文献情報:
Davide F. Robbiani, et al. Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals, bioRxiv 2020
-
備考:
Application: IHC-Fr -
参照:
- No.: 3
-
文献情報:
Hoffmann HH et al. TMEM41B Is a Pan-flavivirus Host Factor. Cell 2021 01;184(1):133-148.e20
Hoffmann HH et al
2021/01/01
-
備考:
-
参照:
- No.: 4
-
文献情報:
Mellott DM et al. A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells. ACS Chem Biol 2021 04;16(4):642-650
Mellott DM et al
2021/01/01
-
備考:
-
参照:
- No.: 6
-
文献情報:
Li J et al. Microfluidic Magneto Immunosensor for Rapid, High Sensitivity Measurements of SARS-CoV-2 Nucleocapsid Protein in Serum. ACS Sens 2021 03;6(3):1270-1278
Li J et al
2021/01/01
-
備考:
-
参照:
- No.: 7
-
文献情報:
Meyer M et al. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge. bioRxiv 2021 Jan;
Meyer M et al
2021/01/01
-
備考:
-
参照:
- No.: 8
-
文献情報:
Lu-Culligan A et al. SARS-CoV-2 infection in pregnancy is associated with robust inflammatory response at the maternal-fetal interface. medRxiv 2021 Jan;
Lu-Culligan A et al
2021/01/01
-
備考:
-
参照:
- No.: 10
-
文献情報:
Mor M et al. Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors. PLoS Pathog 2021 02;17(2):e1009165
Mor M et al
2021/01/01
-
備考:
-
参照:
- No.: 11
-
文献情報:
Schmidt F et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. bioRxiv 2020 Jun;
Schmidt F et al
2020/01/01
-
備考:
-
参照:
- No.: 12
-
文献情報:
Plescia CB et al. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles. J Biol Chem 2020 Nov;
Plescia CB et al
2020/01/01
-
備考:
-
参照:
- No.: 13
-
文献情報:
Schneider WM et al. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. bioRxiv 2020 Oct;
Schneider WM et al
2020/01/01
-
備考:
-
参照:
- No.: 14
-
文献情報:
Robbiani DF et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature 2020 08;584(7821):437-442
Robbiani DF et al
2020/01/01
-
備考:
-
参照:
- No.: 15
-
文献情報:
Clausen TM et al. SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2. Cell 2020 11;183(4):1043-1057.e15
Clausen TM et al
2020/01/01
-
備考:
-
参照:
- No.: 16
-
文献情報:
Robbiani DF et al. Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals. bioRxiv 2020 May;
Robbiani DF et al
2020/01/01
-
備考:
-
参照:
- No.: 17
-
文献情報:
Francica JR et al. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med 2021 08;13(607)
Francica JR et al
2021/01/01
-
備考:
-
参照:
- No.: 18
-
文献情報:
Junqueira C et al. SARS-CoV-2 infects blood monocytes to activate NLRP3 and AIM2 inflammasomes, pyroptosis and cytokine release. Res Sq 2021 Aug;
Junqueira C et al
2021/01/01
-
備考:
-
参照:
- No.: 19
-
文献情報:
Verma R et al. RNA-Protein Interaction Analysis of SARS-CoV-2 5" and 3" Untranslated Regions Reveals a Role of Lysosome-Associated Membrane Protein-2a during Viral Infection. mSystems 2021 Aug;6(4):e0064321
Verma R et al
2021/01/01
-
備考:
-
参照:
- No.: 20
-
文献情報:
Hoffmann HH et al. TMEM41B is a pan-flavivirus host factor. bioRxiv 2020 Oct;
Hoffmann HH et al
2020/01/01
-
備考:
-
参照:
- No.: 21
-
文献情報:
Mor M et al. Multi-Clonal Live SARS-CoV-2 In Vitro Neutralization by Antibodies Isolated from Severe COVID-19 Convalescent Donors. bioRxiv 2020 Oct;
Mor M et al
2020/01/01
-
備考:
-
参照:
- No.: 22
-
文献情報:
Wang Z et al. Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro. bioRxiv 2020 Sep;
Wang Z et al
2020/01/01
-
備考:
-
参照:
- No.: 23
-
文献情報:
Eriksen AZ et al. SARS-CoV-2 infects human adult donor eyes and hESC-derived ocular epithelium. Cell Stem Cell 2021 07;28(7):1205-1220.e7
Eriksen AZ et al
2021/01/01
-
備考:
-
参照:
- No.: 24
-
文献情報:
DiPiazza AT et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity 2021 08;54(8):1869-1882.e6
DiPiazza AT et al
2021/01/01
-
備考:
-
参照:
- No.: 25
-
文献情報:
Li D et al. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell 2021 08;184(16):4203-4219.e32
Li D et al
2021/01/01
-
備考:
-
参照:
- No.: 26
-
文献情報:
Wang Z et al. Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection. Nature 2021 07;595(7867):426-431
Wang Z et al
2021/01/01
-
備考:
-
参照:
- No.: 27
-
文献情報:
. Pharmacological activation of STING blocks SARS-CoV-2 infection. Sci Immunol 2021 05;6(59)
2021/01/01
-
備考:
-
参照:
- No.: 28
-
文献情報:
Schmidt F et al. Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med 2020 11;217(11)
Schmidt F et al
2020/01/01
-
備考:
-
参照:
- No.: 29
-
文献情報:
Sukhikh G et al. Vertical Transmission of SARS-CoV-2 in Second Trimester Associated with Severe Neonatal Pathology. Viruses 2021 03;13(3)
Sukhikh G et al
2021/01/01
-
備考:
-
参照:
- No.: 30
-
文献情報:
Saunders KO et al. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses. Nature 2021 06;594(7864):553-559
Saunders KO et al
2021/01/01
-
備考:
-
参照:
- No.: 31
-
文献情報:
Park SH et al. Interactions of SARS-CoV-2 envelope protein with amilorides correlate with antiviral activity. PLoS Pathog 2021 05;17(5):e1009519
Park SH et al
2021/01/01
-
備考:
-
参照:
- No.: 32
-
文献情報:
Cantwell AM et al. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19. J Virol 2021 09;95(20):e0101021
Cantwell AM et al
2021/01/01
-
備考:
-
参照:
- No.: 33
-
文献情報:
Corbett KS et al. mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates. Nat Immunol 2021 10;22(10):1306-1315
Corbett KS et al
2021/01/01
-
備考:
-
参照:
- No.: 34
-
文献情報:
Corbett KS et al. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates. Science 2021 09;373(6561):eabj0299
Corbett KS et al
2021/01/01
-
備考:
-
参照:
- No.: 35
-
文献情報:
Wagner TR et al. Biparatopic nanobodies protect mice from lethal challenge with SARS-CoV-2 variants of concern. EMBO Rep 2022 02;23(2):e53865
Wagner TR et al
2022/01/01
-
備考:
-
参照:
- No.: 36
-
文献情報:
Yewdell J et al. Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity. Res Sq 2021 Dec;
Yewdell J et al
2021/01/01
-
備考:
-
参照:
- No.: 37
-
文献情報:
Gagne M et al. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung. Cell 2022 01;185(1):113-130.e15
Gagne M et al
2022/01/01
-
備考:
-
参照:
- No.: 38
-
文献情報:
Saiz ML et al. Epigenetic targeting of the ACE2 and NRP1 viral receptors limits SARS-CoV-2 infectivity. Clin Epigenetics 2021 10;13(1):187
Saiz ML et al
2021/01/01
-
備考:
-
参照:
- No.: 39
-
文献情報:
Peng YC et al. A Novel Rapid Test to Detect Anti-SARS-CoV-2 N Protein IgG Based on Shear Horizontal Surface Acoustic Wave (SH-SAW). Diagnostics (Basel) 2021 Oct;11(10)
Peng YC et al
2021/01/01
-
備考:
-
参照:
- No.: 40
-
文献情報:
Kmiec D et al. S-farnesylation is essential for antiviral activity of the long ZAP isoform against RNA viruses with diverse replication strategies. PLoS Pathog 2021 10;17(10):e1009726
Kmiec D et al
2021/01/01
-
備考:
-
参照:
- No.: 41
-
文献情報:
Carapito R et al. Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort. Sci Transl Med 2022 Jan;14(628):eabj7521
Carapito R et al
2022/01/01
-
備考:
-
参照:
- No.: 42
-
文献情報:
Madden PJ et al. An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques. bioRxiv 2022 Mar;
Madden PJ et al
2022/01/01
-
備考:
-
参照:
- No.: 43
-
文献情報:
Piscotta FJ et al. Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals. mSphere 2021 Dec;6(6):e0071121
Piscotta FJ et al
2021/01/01
-
備考:
-
参照:
- No.: 44
-
文献情報:
L坦pez-Mu単oz AD et al. Cell Surface SARS-CoV-2 Nucleocapsid Protein Modulates Innate and Adaptive Immunity. bioRxiv 2021 Dec;
L坦pez-Mu単oz AD et al
2021/01/01
-
備考:
-
参照:
- No.: 45
-
文献情報:
Li X et al. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles. PLoS Pathog 2021 Sep;17(9):e1009898
Li X et al
2021/01/01
-
備考:
-
参照:
- No.: 46
-
文献情報:
Knoblach B et al. Peroxisomes exhibit compromised structure and matrix protein content in SARS-CoV-2-infected cells. Mol Biol Cell 2021 07;32(14):1273-1282
Knoblach B et al
2021/01/01
-
備考:
-
参照:
- No.: 47
-
文献情報:
Lu-Culligan A et al. Maternal respiratory SARS-CoV-2 infection in pregnancy is associated with a robust inflammatory response at the maternal-fetal interface. Med (N Y) 2021 May;2(5):591-610.e10
Lu-Culligan A et al
2021/01/01
-
備考:
-
参照:
- No.: 48
-
文献情報:
Rosado-Olivieri EA et al. Self-organized stem cell-derived human lung buds with proximo-distal patterning and novel targets of SARS-CoV-2. bioRxiv 2021 Jan;
Rosado-Olivieri EA et al
2021/01/01
-
備考:
-
参照:
- No.: 49
-
文献情報:
Hoffmann HH et al. Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Cell Host Microbe 2021 Feb;29(2):267-280.e5
Hoffmann HH et al
2021/01/01
-
備考:
-
参照:
- No.: 50
-
文献情報:
Madden P et al. An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques. Res Sq 2022 Apr;
Madden P et al
2022/01/01
-
備考:
-
参照:
- No.: 51
-
文献情報:
Ariumi Y. Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection. J Virol 2022 Mar;96(6):e0000222
Ariumi Y
2022/01/01
-
備考:
-
参照:
- No.: 52
-
文献情報:
Vora SM et al. Targeting stem-loop 1 of the SARS-CoV-2 5" UTR to suppress viral translation and Nsp1 evasion. Proc Natl Acad Sci U S A 2022 Mar;119(9)
Vora SM et al
2022/01/01
-
備考:
-
参照:
- No.: 53
-
文献情報:
Hsu CJ et al. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19. Microbiol Spectr 2022 Feb;10(1):e0236221
Hsu CJ et al
2022/01/01
-
備考:
-
参照:
- No.: 54
-
文献情報:
Wang Z et al. Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins. bioRxiv 2022 Feb;
Wang Z et al
2022/01/01
-
備考:
-
参照:
- No.: 55
-
文献情報:
Garcia-Flores V et al. Maternal-fetal immune responses in pregnant women infected with SARS-CoV-2. Nat Commun 2022 Jan;13(1):320
Garcia-Flores V et al
2022/01/01
-
備考:
-
参照:
- No.: 56
-
文献情報:
Palladino G et al. Self-amplifying mRNA SARS-CoV-2 vaccines raise cross-reactive immune response to variants and prevent infection in animal models. Mol Ther Methods Clin Dev 2022 Jun;25:225-235
Palladino G et al
2022/01/01
-
備考:
-
参照:
- No.: 57
-
文献情報:
Fern叩ndez-Casta単eda A et al. Mild respiratory SARS-CoV-2 infection can cause multi-lineage cellular dysregulation and myelin loss in the brain. bioRxiv 2022 Jan;
Fern叩ndez-Casta単eda A et al
2022/01/01
-
備考:
-
参照:
- No.: 58
-
文献情報:
Li D et al. Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine. bioRxiv 2022 Feb;
Li D et al
2022/01/01
-
備考:
-
参照:
- No.: 59
-
文献情報:
Chen PH et al. Saliva-based COVID-19 detection: A rapid antigen test of SARS-CoV-2 nucleocapsid protein using an electrical-double-layer gated field-effect transistor-based biosensing system. Sens Actuators B Chem 2022 Apr;357:131415
Chen PH et al
2022/01/01
-
備考:
-
参照:
- No.: 60
-
文献情報:
Wei SC et al. An Integrated Platform for Serological Detection and Vaccination of COVID-19. Front Immunol 2021;12:771011
Wei SC et al
2021/01/01
-
備考:
-
参照:
- No.: 61
-
文献情報:
Bastard P et al. Autoantibodies neutralizing type I IFNs are present in <b>~</b>4% of uninfected individuals over 70 years old and account for <b>~</b>20% of COVID-19 deaths. Sci Immunol 2021 Aug;6(62)
Bastard P et al
2021/01/01
-
備考:
-
参照:
- No.: 62
-
文献情報:
Vanhulle E et al. SARS-CoV-2 Permissive glioblastoma cell line for high throughput antiviral screening. Antiviral Res 2022 Jul;203:105342
Vanhulle E et al
2022/01/01
-
備考:
-
参照:
- No.: 63
-
文献情報:
Vanhulle E et al. Intracellular flow cytometry complements RT-qPCR detection of circulating SARS-CoV-2 variants of concern. Biotechniques 2022 Jun;72(6):245-254
Vanhulle E et al
2022/01/01
-
備考:
-
参照:
- No.: 64
-
文献情報:
Chen M et al. Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants. bioRxiv 2022 Apr;
Chen M et al
2022/01/01
-
備考:
-
参照:
- No.: 65
-
文献情報:
Wang Z et al. Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins. Immunity 2022 Jun;55(6):998-1012.e8
Wang Z et al
2022/01/01
-
備考:
-
参照:
- No.: 66
-
文献情報:
Gagne M et al. mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron. Cell 2022 Apr;185(9):1556-1571.e18
Gagne M et al
2022/01/01
-
備考:
-
参照:
- No.: 67
-
文献情報:
Schneider WM et al. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell 2021 Jan;184(1):120-132.e14
Schneider WM et al
2021/01/01
-
備考:
-
参照:
- No.: 68
-
文献情報:
Wang Z et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci Transl Med 2021 Jan;13(577)
Wang Z et al
2021/01/01
-
備考:
-
参照:
- No.: 69
-
文献情報:
Schumann S et al. Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19. Int J Mol Sci 2020 Nov;21(22)
Schumann S et al
2020/01/01
-
備考:
-
参照:
- No.: 70
-
文献情報:
Li X et al. Ethacridine inhibits SARS-CoV-2 by inactivating viral particles in cellular models. bioRxiv 2020 Oct;
Li X et al
2020/01/01
-
備考:
-
参照:
- No.: 71
-
文献情報:
Mellott DM et al. A cysteine protease inhibitor blocks SARS-CoV-2 infection of human and monkey cells. bioRxiv 2020 Oct;
Mellott DM et al
2020/01/01
-
備考:
-
参照:
- No.: 72
-
文献情報:
Meewan I et al. Discovery of Triple Inhibitors of Both SARS-CoV-2 Proteases and Human Cathepsin L. Pharmaceuticals (Basel) 2022 Jun;15(6)
Meewan I et al
2022/01/01
-
備考:
-
参照:
- No.: 73
-
文献情報:
Setz C et al. Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern. Int J Mol Sci 2022 Jun;23(12)
Setz C et al
2022/01/01
-
備考:
-
参照:
- No.: 74
-
文献情報:
Fern叩ndez-Casta単eda A et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 2022 Jul;185(14):2452-2468.e16
Fern叩ndez-Casta単eda A et al
2022/01/01
-
備考:
-
参照:
- No.: 75
-
文献情報:
Wang Q et al. Functional properties of the spike glycoprotein of the emerging SARS-CoV-2 variant B.1.1.529. Cell Rep 2022 Jun;39(11):110924
Wang Q et al
2022/01/01
-
備考:
-
参照:
- No.: 76
-
文献情報:
Ueha R et al. Oral SARS-CoV-2 Inoculation Causes Nasal Viral Infection Leading to Olfactory Bulb Infection: An Experimental Study. Front Cell Infect Microbiol 2022;12:924725
Ueha R et al
2022/01/01
-
備考:
-
参照:
- No.: 77
-
文献情報:
Eriksen AZ et al. Protocols for SARS-CoV-2 infection in primary ocular cells and eye organoids. STAR Protoc 2022 Jun;3(2):101383
Eriksen AZ et al
2022/01/01
-
備考:
-
参照:
- No.: 79
-
文献情報:
Lebedin M et al. Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses. iScience 2024 Mar;27(3):109330
Lebedin M et al
2024/01/01
-
備考:
-
参照:
- No.: 80
-
文献情報:
Ostendorf BN et al. Common human genetic variants of APOE impact murine COVID-19 mortality. Nature 2022 Nov;611(7935):346-351
Ostendorf BN et al
2022/01/01
-
備考:
-
参照:
- No.: 81
-
文献情報:
Malewana RD et al. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates. bioRxiv 2023 Dec;
Malewana RD et al
2023/01/01
-
備考:
-
参照:
- No.: 82
-
文献情報:
S Mesquita F et al. SARS-CoV-2 hijacks a cell damage response, which induces transcription of a more efficient Spike S-acyltransferase. Nat Commun 2023 Nov;14(1):7302
S Mesquita F et al
2023/01/01
-
備考:
-
参照:
- No.: 83
-
文献情報:
Schmidt N et al. SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. Cell 2023 Oct;186(22):4834-4850.e23
Schmidt N et al
2023/01/01
-
備考:
-
参照:
- No.: 84
-
文献情報:
Flamier A et al. Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2. iScience 2023 Sep;26(9):107690
Flamier A et al
2023/01/01
-
備考:
-
参照:
- No.: 85
-
文献情報:
Li M et al. SARS-CoV-2 ORF6 protein does not antagonize interferon signaling in respiratory epithelial Calu-3 cells during infection. mBio 2023 Aug;14(4):e0119423
Li M et al
2023/01/01
-
備考:
-
参照:
- No.: 86
-
文献情報:
Di Primio C et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus 2023 Sep;2(9):pgad282
Di Primio C et al
2023/01/01
-
備考:
-
参照:
- No.: 87
-
文献情報:
Resnick JD et al. Growth media affects susceptibility of air-lifted human nasal epithelial cell cultures to SARS-CoV2, but not Influenza A, virus infection. bioRxiv 2023 Aug;
Resnick JD et al
2023/01/01
-
備考:
-
参照:
- No.: 88
-
文献情報:
Lee D et al. Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children. Science 2023 Feb;379(6632):eabo3627
Lee D et al
2023/01/01
-
備考:
-
参照:
- No.: 89
-
文献情報:
Flamier A et al. Human iPS cell-derived sensory neurons can be infected by SARS-CoV-2 strain WA1/2020 as well as variants delta and omicron. bioRxiv 2023 Jan;
Flamier A et al
2023/01/01
-
備考:
-
参照:
- No.: 90
-
文献情報:
de Melo GD et al. Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants. Nat Commun 2023 Jul;14(1):4485
de Melo GD et al
2023/01/01
-
備考:
-
参照:
- No.: 91
-
文献情報:
Yang J et al. Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2. Nat Microbiol 2023 Jan;8(1):121-134
Yang J et al
2023/01/01
-
備考:
-
参照:
- No.: 92
-
文献情報:
Pillai S et al. A Novel Viral Assembly Inhibitor Blocks SARS-CoV-2 Replication in Airway Epithelial Cells. Res Sq 2023 May;
Pillai S et al
2023/01/01
-
備考:
-
参照:
- No.: 93
-
文献情報:
Berry C et al. Beta-containing bivalent SARS-CoV-2 protein vaccine elicits durable broad neutralization in macaques and protection in hamsters. Commun Med (Lond) 2023 May;3(1):75
Berry C et al
2023/01/01
-
備考:
-
参照:
- No.: 94
-
文献情報:
Lopez-Orozco J et al. The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2. J Mol Biol 2023 Aug;435(16):168170
Lopez-Orozco J et al
2023/01/01
-
備考:
-
参照:
- No.: 95
-
文献情報:
Alena Reguzova et al., A novel multi-antigenic parapoxvirus-based vaccine demonstrates efficacy in protecting hamsters and non-human primates against SARS-CoV-2 challenge., Research Square., 2023.,
-
備考:
-
参照:
- No.: 96
-
文献情報:
Carlin AF et al. Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir Treatment. Open Forum Infect Dis 2023 Apr;10(4
Carlin AF et al
2023/01/01
-
備考:
-
参照:
- No.: 97
-
文献情報:
Hastie KM et al. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep 2023 May;42(5):112421
Hastie KM et al
2023/01/01
-
備考:
-
参照:
- No.: 98
-
文献情報:
Routhu NK et al. Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in nonhuman primates. Sci Immunol 2023 Oct;8(88):eadg7015
Routhu NK et al
2023/01/01
-
備考:
-
参照:
- No.: 99
-
文献情報:
Satish Pillai et al., A Novel Viral Assembly Inhibitor Blocks SARS-CoV-2 Replication in Airway Epithelial Cells., Research Square., 2023.,
-
備考:
-
参照:
- No.: 100
-
文献情報:
F. van der Goot et al., SARS-CoV-2 shifts transcription of host gene to increase Spike acylation and boost infectivity., Research Square., 2023.,
-
備考:
-
参照:
- No.: 101
-
文献情報:
Zhang F et al. Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies. Nat Microbiol 2023 Jun;8(6):1051-1063
Zhang F et al
2023/01/01
-
備考:
-
参照:
- No.: 102
-
文献情報:
Zhang L et al. LINE1-Mediated Reverse Transcription and Genomic Integration of SARS-CoV-2 mRNA Detected in Virus-Infected but Not in Viral mRNA-Transfected Cells. Viruses 2023 Feb;15(3)
Zhang L et al
2023/01/01
-
備考:
-
参照:
- No.: 103
-
文献情報:
Carlin AF et al. 1-<i>O</i>-Octadecyl-2-<i>O</i>-benzyl-<i>sn</i>-glyceryl-3-<i>phospho</i>-GS-441524 (V2043). Evaluation of Oral V2043 in a Mouse Model of SARS-CoV-2 Infection and Synthesis and Antiviral Evaluation of Additional Phospholipid Esters with
Carlin AF et al
2023/01/01
-
備考:
-
参照:
- No.: 104
-
文献情報:
Ueha R et al. Evidence for the spread of SARS-CoV-2 and olfactory cell lineage impairment in close-contact infection Syrian hamster models. Front Cell Infect Microbiol 2022;12:1019723
Ueha R et al
2022/01/01
-
備考:
-
参照:
- No.: 105
-
文献情報:
Yeung ST et al. Galectin-9 protects humanized-ACE2 immunocompetent mice from SARS-CoV-2 infection. Front Immunol 2022;13:1011185
Yeung ST et al
2022/01/01
-
備考:
-
参照:
- No.: 106
-
文献情報:
Li D et al. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine. Nat Commun 2022 Oct;13(1):6309
Li D et al
2022/01/01
-
備考:
-
参照:
- No.: 107
-
文献情報:
Takeda R et al. Antiviral effect of cetylpyridinium chloride in mouthwash on SARS-CoV-2. Sci Rep 2022 Aug;12(1):14050
Takeda R et al
2022/01/01
-
備考:
-
参照:
- No.: 108
-
文献情報:
Groテ歹 M et al. Inhibitors of Deubiquitinating Enzymes Interfere with the SARS-CoV-2 Papain-like Protease and Block Virus Replication In Vitro. Viruses 2022 Jun;14(7)
Groテ歹 M et al
2022/01/01
-
備考:
-
参照:
- No.: 109
-
文献情報:
S淡rensen DM et al. Identification of global inhibitors of cellular glycosylation. Nat Commun 2023 Feb;14(1):948
S淡rensen DM et al
2023/01/01
-
備考:
-
参照:
- No.: 110
-
文献情報:
Rosain J et al. Human IRF1 governs macrophagic IFN-γ immunity to mycobacteria. Cell 2023 Feb;186(3):621-645.e33
Rosain J et al
2023/01/01
-
備考:
-
参照:
- No.: 111
-
文献情報:
Pereira de Jesus BA et al. In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein. Viruses 2022 Dec;14(12)
Pereira de Jesus BA et al
2022/01/01
-
備考:
-
参照:
- No.: 112
-
文献情報:
Polo-Meg鱈as D et al. Exploring Highly Conserved Regions of SARS-CoV-2 Spike S2 Subunit as Targets for Fusion Inhibition Using Chimeric Proteins. Int J Mol Sci 2022 Dec;23(24)
Polo-Meg鱈as D et al
2022/01/01
-
備考:
-
参照:
- No.: 113
-
文献情報:
Ogura H et al. Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19. Nat Commun 2022 Dec;13(1):7063
Ogura H et al
2022/01/01
-
備考:
-
参照:
- No.: 114
-
文献情報:
Arai Y et al. Stimulation of interferon-β responses by aberrant SARS-CoV-2 small viral RNAs acting as retinoic acid-inducible gene-I agonists. iScience 2023 Jan;26(1):105742
Arai Y et al
2023/01/01
-
備考:
-
参照:
- No.: 115
-
文献情報:
Lista MJ et al. The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance. J Virol 2022 Dec;96(23):e0125022
Lista MJ et al
2022/01/01
-
備考:
-
参照:
- No.: 116
-
文献情報:
Cano-Mu単oz M et al. Novel chimeric proteins mimicking SARS-CoV-2 spike epitopes with broad inhibitory activity. Int J Biol Macromol 2022 Dec;222(Pt B):2467-2478
Cano-Mu単oz M et al
2022/01/01
-
備考:
-
参照:
- No.: 117
-
文献情報:
Kumar CS et al. Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells. ACS Infect Dis 2022 Oct;8(10):2119-2132
Kumar CS et al
2022/01/01
-
備考:
-
参照:
- No.: 118
-
文献情報:
Vanhulle E et al. Carbohydrate-binding protein from stinging nettle as fusion inhibitor for SARS-CoV-2 variants of concern. Front Cell Infect Microbiol 2022;12:989534
Vanhulle E et al
2022/01/01
-
備考:
-
参照:
- No.: 119
-
文献情報:
Li R et al. Conformational flexibility in neutralization of SARS-CoV-2 by naturally elicited anti-SARS-CoV-2 antibodies. Commun Biol 2022 Aug;5(1):789
Li R et al
2022/01/01
-
備考:
-
参照:
- No.: 120
-
文献情報:
Almanza G et al. Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern. PLoS Pathog 2022 Jul;18(7):e1010686
Almanza G et al
2022/01/01
-
備考:
-
参照:
- No.: 121
-
文献情報:
Zekri L et al. Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants <i>in vitro</i>. Front Immunol 2023;14:1112505
Zekri L et al
2023/01/01
-
備考:
-
参照:
- No.: 122
-
文献情報:
Cheshenko N et al. Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2. Commun Biol 2022 Oct;5(1):1096
Cheshenko N et al
2022/01/01
-
備考:
-
参照:
- No.: 123
-
文献情報:
Richards A et al. SARS-CoV-2 infection of human pluripotent stem cell-derived liver organoids reveals potential mechanisms of liver pathology. iScience 2022 Oct;25(10):105146
Richards A et al
2022/01/01
-
備考:
-
参照:
- No.: 124
-
文献情報:
Nguyen LC et al. SARS-CoV-2 Diverges from Other Betacoronaviruses in Only Partially Activating the IRE1α/XBP1 Endoplasmic Reticulum Stress Pathway in Human Lung-Derived Cells. mBio 2022 Oct;13(5):e0241522
Nguyen LC et al
2022/01/01
-
備考:
-
参照:
- No.: 125
-
文献情報:
Nguyen LC et al. SARS-CoV-2 diverges from other betacoronaviruses in only partially activating the IRE1α/XBP1 ER stress pathway in human lung-derived cells. bioRxiv 2022 Jun;
Nguyen LC et al
2022/01/01
-
備考:
-
参照:
- No.: 126
-
文献情報:
Suryawanshi RK et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature 2022 Jul;607(7918):351-355
Suryawanshi RK et al
2022/01/01
-
備考:
-
参照:
- No.: 127
-
文献情報:
Yeh CT et al. Immunoglobulin Y Specific for SARS-CoV-2 Spike Protein Subunits Effectively Neutralizes SARS-CoV-2 Infectivity and Ameliorates Disease Manifestations In Vivo. Biomedicines 2022 Nov;10(11)
Yeh CT et al
2022/01/01
-
備考:
-
参照:
- No.: 128
-
文献情報:
Ahmed-Belkacem A et al. Third Early "Booster" Dose Strategy in France of bnt162b2 SARS-CoV-2 Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients Enhances Neutralizing Antibody Responses. Viruses 2022 Aug;14(9)
Ahmed-Belkacem A et al
2022/01/01
-
備考:
-
参照:
- No.: 129
-
文献情報:
Zhang Z et al. Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat Commun 2022 Aug;13(1):4399
Zhang Z et al
2022/01/01
-
備考:
-
参照:
- No.: 130
-
文献情報:
L坦pez-Mu単oz AD et al. Cell surface SARS-CoV-2 nucleocapsid protein modulates innate and adaptive immunity. Sci Adv 2022 Aug;8(31):eabp9770
L坦pez-Mu単oz AD et al
2022/01/01
-
備考:
-
参照:
- No.: 131
-
文献情報:
Cheng Y et al. Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells. ACS Nano 2022 Aug;16(8):12305-12317
Cheng Y et al
2022/01/01
-
備考:
-
参照:
- No.: 132
-
文献情報:
Chen IP et al. Viral E protein neutralizes BET protein-mediated post-entry antagonism of SARS-CoV-2. Cell Rep 2022 Jul;40(3):111088
Chen IP et al
2022/01/01
-
備考:
-
参照:
- No.: 133
-
文献情報:
Gregoire C et al. Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism. Immunity 2022 Jul;55(7):1216-1233.e9
Gregoire C et al
2022/01/01
-
備考:
-
参照:
- No.: 134
-
文献情報:
Zhang Q et al. Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med 2022 Aug;219(8)
Zhang Q et al
2022/01/01
-
備考:
-
参照:
- No.: 135
-
文献情報:
Moliva JI et al. Durable immunity to SARS-CoV-2 in both lower and upper airways achieved with a gorilla adenovirus (GRAd) S-2P vaccine in non-human primates. bioRxiv 2023 Nov;
Moliva JI et al
2023/01/01
-
備考:
-
参照: